4502.T - Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
JPMorganEstimate Revision, Price Target Increase

Takeda Pharmaceutical (4502) We expect share price to correct temporarily after March events (dividend, AAD) as we expect guidance for a FY2026 profit decline

公司
4502.T
日期
2026-02-25
分析师
Mr. Seiji Wakao
页数
34 页
需要登录
请登录后购买研报或生成音频内容。